Date	Period	Revenue/Estimate	Earnings Call
Jul 30, 2025	2026/Q1	-- / 1.127T	--
May 8, 2025	2025/Q4	-- / 1.097T	--
Jan 30, 2025	2025/Q3	1.144T / 1.132T	--
Oct 31, 2024	2025/Q2	1.176T / 1.079T	--
Jul 31, 2024	2025/Q1	1.208T / 1.081T	--

DatePeriodRevenue/EstimateEarnings Call

Jul 30, 20252026/Q1-- / 1.127T--

May 8, 20252025/Q4-- / 1.097T--

Jan 30, 20252025/Q31.144T / 1.132T--

Oct 31, 20242025/Q21.176T / 1.079T--

Jul 31, 20242025/Q11.208T / 1.081T--

Unlock Free Earnings Estimates

Open Account

Takeda Pharmaceutical: Extraordinary Report

Jan 30 02:02 ET

Takeda Pharmaceutical: Notice regarding revisions to full-year earnings forecasts (IFRS)

Jan 30 01:30 ET

Takeda Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [IFRS] (consolidated)

Jan 30 01:30 ET

Takeda Pharmaceutical: Revised Extraordinary Report

Dec 17, 2024 23:02 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Feb 12, 2025

Buy

No Data